scholarly article | Q13442814 |
P50 | author | Ilaria Ferlenghi | Q114321023 |
Fabiola Giusti | Q114321035 | ||
P2093 | author name string | Mark H Kaplan | |
Eric Lorenzo | |||
David M Markovitz | |||
Yasuhiro Yamamura | |||
Scott D Gitlin | |||
Marta J Gonzalez-Hernandez | |||
Rafael Contreras-Galindo | |||
Angie C Contreras-Galindo | |||
Michael H Dosik | |||
P2860 | cites work | Reconstitution of an infectious human endogenous retrovirus | Q21559512 |
HERVd: the Human Endogenous RetroViruses Database: update | Q22330793 | ||
Long-term reinfection of the human genome by endogenous retroviruses | Q23067953 | ||
Demystified. Human endogenous retroviruses | Q23067954 | ||
Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K | Q24527314 | ||
Retroelements and the human genome: new perspectives on an old relation | Q24563781 | ||
Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements | Q24676640 | ||
Comprehensive search for intra- and inter-specific sequence polymorphisms among coding envelope genes of retroviral origin found in the human genome: genes and pseudogenes | Q24816649 | ||
Confidence Limits on Phylogenies: an Approach using the Bootstrap | Q26778379 | ||
PAML: a program package for phylogenetic analysis by maximum likelihood | Q27861096 | ||
Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin | Q28264707 | ||
Antisense transcription in gammaretroviruses as a mechanism of insertional activation of host genes | Q28272333 | ||
Reconstitution of the ancestral glycoprotein of human endogenous retrovirus k and modulation of its functional activity by truncation of the cytoplasmic domain | Q28749689 | ||
PAL2NAL: robust conversion of protein sequence alignments into the corresponding codon alignments | Q29617502 | ||
Recombination Analysis Tool (RAT): a program for the high-throughput detection of recombination | Q30836902 | ||
Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping | Q30991796 | ||
Proviral structure, chromosomal location, and expression of HERV-K-T47D, a novel human endogenous retrovirus derived from T47D particles. | Q32023465 | ||
Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis | Q33592278 | ||
Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans | Q33872725 | ||
Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome | Q33928303 | ||
The amino acid following an asn-X-Ser/Thr sequon is an important determinant of N-linked core glycosylation efficiency | Q34066483 | ||
Evidence for genomic rearrangements mediated by human endogenous retroviruses during primate evolution | Q34101407 | ||
Identification of a functional envelope protein from the HERV-K family of human endogenous retroviruses | Q34228519 | ||
Transcriptional interference in avian retroviruses—implications for the promoter insertion model of leukaemogenesis | Q34257238 | ||
The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription | Q34350825 | ||
Tempo and mode of ERV-K evolution in human and chimpanzee genomes | Q34546082 | ||
Analysis of HIV-1 expression level and sense of transcription by high-throughput sequencing of the infected cell | Q35077515 | ||
Expression pattern analysis of transcribed HERV sequences is complicated by ex vivo recombination. | Q35865271 | ||
Human endogenous retrovirus K solo-LTR formation and insertional polymorphisms: implications for human and viral evolution | Q36161323 | ||
A novel centromeric repetitive DNA from human chromosome 22. | Q36441084 | ||
Characterization of novel reverse transcriptase encoding human endogenous retroviral sequences similar to type A and type B retroviruses: differential transcription in normal human tissues | Q36654574 | ||
Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer | Q36898870 | ||
The remarkable frequency of human immunodeficiency virus type 1 genetic recombination | Q37333701 | ||
Antigenic drift as a mechanism for tumor evasion of destruction by cytolytic T lymphocytes | Q39752699 | ||
Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals | Q42601873 | ||
Hepatitis C virus particle detected by immunoelectron microscopic study | Q43035885 | ||
Evolutionary dynamics of the human endogenous retrovirus family HERV-K inferred from full-length proviral genomes | Q44601381 | ||
Phylogenetic reconstruction of intrapatient evolution of human immunodeficiency virus type 1: predominance of drift and purifying selection | Q45736875 | ||
Allelic variation of HERV-K(HML-2) endogenous retroviral elements in human populations. | Q46238444 | ||
A new Real-Time-RT-PCR for quantitation of human endogenous retroviruses type K (HERV-K) RNA load in plasma samples: increased HERV-K RNA titers in HIV-1 patients with HAART non-suppressive regimens. | Q50731253 | ||
RDP2: recombination detection and analysis from sequence alignments. | Q51989136 | ||
Evaluation of two TaqMan PCR assays for the detection of HIV-1 proviral DNA in blood samples. | Q54642664 | ||
Insertional polymorphisms of full-length endogenous retroviruses in humans | Q74601227 | ||
Changes in ds/dn in the HIV-1 env gene | Q77769177 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 262-276 | |
P577 | publication date | 2011-10-26 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals | |
P478 | volume | 86 |
Q30842942 | "Reverse genomics" and human endogenous retroviruses |
Q24289157 | 'There and back again': revisiting the pathophysiological roles of human endogenous retroviruses in the post-genomic era |
Q38613558 | Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers |
Q27011469 | Are human endogenous retroviruses pathogenic? An approach to testing the hypothesis |
Q89702908 | Characterising a human endogenous retrovirus(HERV)-derived tumour-associated antigen: enriched RNA-Seq analysis of HERV-K(HML-2) in mantle cell lymphoma cell lines |
Q42275490 | Detection of Human Endogenous Retrovirus K (HERV-K) Transcripts in Human Prostate Cancer Cell Lines. |
Q38807639 | Determination of Sequences Required for Human Endogenous Retrovirus K Transduction and Its Recognition by Foreign Retroviral Virions |
Q35232788 | Differential expression of HERV-K (HML-2) proviruses in cells and virions of the teratocarcinoma cell line Tera-1. |
Q34240041 | Diminished humoral responses against and reduced gene expression levels of human endogenous retrovirus-K (HERV-K) in psoriasis |
Q36831433 | Discovery of unfixed endogenous retrovirus insertions in diverse human populations |
Q58796885 | Disruption by SaCas9 Endonuclease of HERV-K, a Retroviral Gene with Oncogenic and Neuropathogenic Potential, Inhibits Molecules Involved in Cancer and Amyotrophic Lateral Sclerosis |
Q38917776 | ERVK polyprotein processing and reverse transcriptase expression in human cell line models of neurological disease |
Q93221976 | ERVmap analysis reveals genome-wide transcription of human endogenous retroviruses |
Q38241314 | Endogenous retrovirus-K and nervous system diseases |
Q26852000 | Endogenous retroviruses and the development of cancer |
Q29619890 | Endogenous viruses: insights into viral evolution and impact on host biology |
Q45756577 | Env gene expression of human endogenous retrovirus-k and human endogenous retrovirus-w in childhood acute leukemia cells |
Q35588462 | Expansion of a novel endogenous retrovirus throughout the pericentromeres of modern humans |
Q38671900 | Expression of HERV-K108 envelope interferes with HIV-1 production |
Q36171859 | Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1. |
Q35035666 | Frequency of human endogenous retroviral sequences (HERV) K113 and K115 in the Polish population, and their effect on HIV infection |
Q36466553 | Further Evidence that Human Endogenous Retrovirus K102 is a Replication Competent Foamy Virus that may Antagonize HIV-1 Replication |
Q35575837 | Genome-wide amplification of proviral sequences reveals new polymorphic HERV-K(HML-2) proviruses in humans and chimpanzees that are absent from genome assemblies |
Q35154110 | HERV-K(HML-2) rec and np9 transcripts not restricted to disease but present in many normal human tissues. |
Q34511101 | HERV-K(HML-2), a seemingly silent subtenant - but still waters run deep |
Q37186225 | HERV-K(HML-2), the Best Preserved Family of HERVs: Endogenization, Expression, and Implications in Health and Disease |
Q37976105 | HIV infection and HERV expression: a review |
Q28681264 | HIV infection reveals widespread expansion of novel centromeric human endogenous retroviruses |
Q42697771 | HIV-1 Infection of Primary CD4+ T Cells Regulates the Expression of Specific Human Endogenous Retrovirus HERV-K (HML-2) Elements |
Q92017208 | HIV-1 Rev interacts with HERV-K RcREs present in the human genome and promotes export of unspliced HERV-K proviral RNA |
Q34262010 | HIV-1 infection leads to increased transcription of human endogenous retrovirus HERV-K (HML-2) proviruses in vivo but not to increased virion production |
Q33887743 | HIV-1 interacts with human endogenous retrovirus K (HML-2) envelopes derived from human primary lymphocytes |
Q37123276 | High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects. |
Q35758600 | Human Endogenous Retrovirus Type K (HERV-K) Particles Package and Transmit HERV-K-Related Sequences |
Q36276266 | Human endogenous retrovirus K Gag coassembles with HIV-1 Gag and reduces the release efficiency and infectivity of HIV-1. |
Q34033196 | Human endogenous retrovirus W activity in cartilage of osteoarthritis patients |
Q57466814 | Human endogenous retrovirus-K (HML-2): a comprehensive review |
Q33837077 | Human endogenous retrovirus-K(II) envelope induction protects neurons during HIV/AIDS. |
Q36810793 | Human immunodeficiency virus, herpes virus infections, and pulmonary vascular disease |
Q52721500 | Hypothetical endogenous SIV-like antigens in Mauritian cynomolgus macaques. |
Q35719448 | Induction and characterization of a replication competent cervid endogenous gammaretrovirus (CrERV) from mule deer cells |
Q36694049 | Infectious Entry Pathway Mediated by the Human Endogenous Retrovirus K Envelope Protein. |
Q90284021 | Is the HERV-K HML-2 Xq21.33, an endogenous retrovirus mutated by gene conversion of chromosome X in a subset of African populations, associated with human breast cancer? |
Q40046573 | Making a virtue of necessity: the pleiotropic role of human endogenous retroviruses in cancer. |
Q34465478 | Microarray analysis reveals global modulation of endogenous retroelement transcription by microbes. |
Q38885663 | Modulation of human endogenous retrovirus (HERV) transcription during persistent and de novo HIV-1 infection |
Q40226566 | Molecular mechanisms by which HERV-K Gag interferes with HIV-1 Gag assembly and particle infectivity |
Q41923513 | Natural and cross-inducible anti-SIV antibodies in Mauritian cynomolgus macaques |
Q36006436 | Potential functional applications of extracellular vesicles: a report by the NIH Common Fund Extracellular RNA Communication Consortium |
Q47579169 | Rapid molecular assays to study human centromere genomics. |
Q34059199 | Regulation of the human endogenous retrovirus K (HML-2) transcriptome by the HIV-1 Tat protein |
Q59355444 | Related Endogenous Retrovirus-K Elements Harbor Distinct Protease Active Site Motifs |
Q64070092 | Structural variation of centromeric endogenous retroviruses in human populations and their impact on cutaneous T-cell lymphoma, Sézary syndrome, and HIV infection |
Q41933413 | Susceptibility of Human Endogenous Retrovirus Type-K to Reverse Transcriptase Inhibitors |
Q90375354 | Telescope: Characterization of the retrotranscriptome by accurate estimation of transposable element expression |
Q92377866 | The Genomic Landscape of Centromeres in Cancers |
Q64091828 | The HERV-K accessory protein Np9 controls viability and migration of teratocarcinoma cells |
Q38673415 | The potential role of retroviruses in autoimmunity |
Q35654719 | Therapeutic applications of extracellular vesicles: clinical promise and open questions |
Q37534896 | Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection |
Q53070552 | Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment. |
Q58803090 | Transcriptional profiling of HERV-K(HML-2) in amyotrophic lateral sclerosis and potential implications for expression of HML-2 proteins |
Q28654487 | Unfixed endogenous retroviral insertions in the human population |
Q27315009 | Vaccination against endogenous retrotransposable element consensus sequences does not protect rhesus macaques from SIVsmE660 infection and replication |
Q64955735 | Variable Baseline Papio cynocephalus Endogenous Retrovirus (PcEV) Expression Is Upregulated in Acutely SIV-Infected Macaques and Correlated to STAT1 Expression in the Spleen. |
Q28672938 | Variant splicing and influence of ionizing radiation on human endogenous retrovirus K (HERV-K) transcripts in cancer cell lines |
Search more.